Immunome
IMNM
IMNM
28 hedge funds and large institutions have $4.85M invested in Immunome in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
52% less capital invested
Capital invested by funds: $10.1M → $4.85M (-$5.25M)
Holders
28
Holding in Top 10
–
Calls
$6K
Puts
$6K
Top Buyers
| 1 | +$48.5K | |
| 2 | +$24.3K | |
| 3 | +$5.07K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5K |
| 5 |
BlackRock
New York
|
+$1.14K |
Top Sellers
| 1 | -$649K | |
| 2 | -$86K | |
| 3 | -$32.7K | |
| 4 |
Cerity Partners
New York
|
-$7.99K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.35K |